Gautam Jayram, Neal D. Shore, Amirali Salmasi, Arman Walia, Leslie Aguilar, Timothy Burn, Christine Francis Lihou, Viraj Degaonkar, Erik T. Goluboff, Dinesh Ganapathy, Seth P. Lerner. "A phase 2 multicenter, open-label study evaluating the efficacy and safety of dabogratinib (TYRA-300) in participants with FGFR3-altered low-grade, intermediate risk non-muscle invasive bladder cancer (SURF302).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.tps886